LimPrOn: Limburg Pre-eclampsia Investigation
Background: Multiple adaptations at the cardiovascular system occurs during pregnancy. In the pregnancy condition pre-eclampsia (PE), this adaptations are abnormal. Five to eight percent of all pregnant women worldwide will develop PE. PE is a pregnancy condition which is characterized with a high blood pressure (\>140/90 mm Hg) and the occurrence of proteinuria (\>3g/dl/24h) after 20 weeks of gestation. When untreated, this condition can have severe complications for both mother and child. It's important to…
Conditions studied
Pregnancy, Pre-eclampsia
About this study
Background: Multiple adaptations at the cardiovascular system occurs during pregnancy. In the pregnancy condition pre-eclampsia (PE), this adaptations are abnormal. Five to eight percent of all pregnant women worldwide will develop PE. PE is a pregnancy condition which is characterized with a high blood pressure (\>140/90 mm Hg) and the occurrence of proteinuria (\>3g/dl/24h) after 20 weeks of gestation. When untreated, this condition can have severe complications for both mother and child. It's important to monitor women with a high risk for developing PE for an early detection and treatment of this condition. For this reason, a multicenter study is set up with the following applications: 1. NICCOMO and Maternal Venous Doppler Echography: impedance cardiograph and an echography of the heart and veins. 2. Maltron: bio-electronic impedance analyze 3. Remote monitoring of the high risk patients to become a more intensive follow-up Number of inclusions: 2000 pregnant women from the prenatal consultations of eight different hospitals:
Interventions
- Device: remote monitoring — Intervention Description: Patients can participate in the study when they're 10 weeks pregnant. At 10 weeks: a NICCOMO, Maternal Venous Doppler Echography and Maltron measurement will be taken. This measurement will be repeated at 20 weeks of pregnancy, and 30 weeks of pregnancy when they're aberrant. When the measurements are abnormal, the patients will be included in the remote monitoring study. The following protocol and devices will be applied: Device What When Withings Wireless Blood Pressure Monitor Blood Pressure 2x/day Withings Pulse O² Activity Day and night Withings Smart Body Analyzer Weight 1x/day
Primary outcomes
- Niccomo measurement (10 weeks of pregnancy)
- Niccomo measurement (20 weeks of pregnancy)
- Systolic and Diastolic Blood pressure monitoring (10 weeks of pregnancy)
- Systolic and Diastolic Blood pressure monitoring (20 weeks of pregnancy)
- a maternal Venous Doppler Echochraphy (10 weeks of pregnancy)
- Maltron measurement (10 weeks of pregnancy)
- a maternal Venous Doppler Echochraphy (20 weeks of pregnancy)
- Maltron measurement (20 weeks of pregnancy)
Eligibility information
Study locations
- Ziekenhuis Maas en Kempen, Bree, Belgium
- Ziekenhuis Oost-Limburg, Genk, 3600 Belgium
- Jessa Ziekenhuis, Hasselt, 3500 Belgium
- Sint-Fransiscus Ziekenhuis, Heusden-Zolder, Belgium
- Heilig Hart Ziekenhuis, Mol, Belgium
- Mariaziekenhuis Oost-Limburg, Overpelt, Belgium
- Sint-Trudo ziekenhuis, Sint-Truiden, Belgium
- AZ-vesalius, Tongeren, Belgium
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.